Yeedozencom now has provided 300+ clinical trials and RA services for 100+ customers at home and abroad, and undergone strict quality audit and inspection. Meanwhile, we have rich experience in BE studies.
Clinical Research, Biological Analysis, SMO Services, Data Mgt. & Biost...Learn more
RA Service for Imported and Domestic Products, RA/Technology Consulting, R&...Learn more
Supplier Quality Audit, R&D Site Inspection, ManufacturingSite Inspecti...Learn more
protocl design and writing, medical support, medical monitoring, PVLearn more
Low-energy Radio-isotope Labeling Technology,QWBA,Drug Metabolite, MIST, Hu...Learn more
New Achievement of Yeedozencom：Fluoxetine Hydrochloride Capsules of Qianyuan Pharmaceutical have Successfully Passed the Consistency Evaluation of Generic Drugs
Recently, Shanxi Qianyuan Pharmaceutical Group Co., Ltd. received "Drug Supplement Application Approval" of its Fluoxetine Hydrochloride Capsules, which was approved and issued by NMPA. The product has passed the “Consistency evaluation of generic drugs” .
YEEDOZENCOM Appears at China Focus @ San Francisco 2020
The China Focus @ San Francisco 2020 was solemnly held in San Francisco, the United States on January 12, local time. As the largest China theme docking event in the JP Morgan Conference Week, this conference attracted more than 50 senior executives from well-known Chinese and foreign pharmaceutical companies and investment institutions, roadshows of 40 innovative companies and nearly 700 participants from China, the United States, Europe, Canada, Japan, South Korea and other countries.
Yeedozencom: Ten years of hardships and efforts, remain true to our original aspiration and keep our mission firmly in mind
A leading CRO with in-depth and compassionate attitude in China! Your best partner to get your products into China!
Arbor Day | Make our earth more beautiful
Yeedozencom, a CRO service provider of full lifecycle technical services for pharmaceutical products, with in-depth and compassionate attitude!
Looking at Biomedical R&D trends from JPM Healthcare conference 2020
Innovative products / technologies will continue to be a key driver of focus in this area in 2020...
Strategic Cooperation Agreement Between Zhenshi Biotechnology and Yeedozencom on All-round Cooperation in R&D of Innovative Drugs and Generic Drugs
Henan Zhenshi Biotechnology Co., Ltd. (hereinafter referred to as “Zhenshi Biotechnology”) and Beijing Yeedozencom Health Technology Co., Ltd. (hereinafter referred to as “Yeedozencom”) entered into a strategic cooperation agreement on Jul. 4, 2019 to establish the all-round partnership in terms of the research and development of innovative drugs and generic drugs.